Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
35.16 USD | -3.59% | -9.54% | +26.83% |
05-24 | Ptc Therapeutics Insider Sold Shares Worth $764,800, According to a Recent SEC Filing | MT |
05-21 | Goldman Sachs Adjusts PTC Therapeutics Price Target to $32 From $18, Maintains Sell Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.83% | 2.8B | |
+8.68% | 115B | |
+9.71% | 105B | |
-12.00% | 22.71B | |
+2.21% | 21.83B | |
-10.88% | 18.18B | |
-41.90% | 16.52B | |
-17.06% | 16.01B | |
+1.72% | 14.14B | |
+20.88% | 10.71B |
- Stock Market
- Equities
- PTCT Stock
- News PTC Therapeutics, Inc.
- Sector Update: Health Care